Skip Navigation


Human Molecular Genetics Advance Access originally published online on July 23, 2009
Human Molecular Genetics 2009 18(20):3942-3954; doi:10.1093/hmg/ddp336
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/20/3942    most recent
ddp336v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smith, R.
Right arrow Articles by Li, J.-Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R.
Right arrow Articles by Li, J.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Mutant huntingtin interacts with β-tubulin and disrupts vesicular transport and insulin secretion

Ruben Smith1,{dagger}, Karl Bacos2,{dagger}, Valentina Fedele1, Denis Soulet1, Helena A. Walz4, Stefanie Obermüller3, Anders Lindqvist3, Maria Björkqvist1, Pontus Klein1, Patrik Önnerfjord5, Patrik Brundin1, Hindrik Mulder2 and Jia-Yi Li1,*

1 Neuronal Survival Unit, BMC A10, Department of Experimental Medical Science, Lund University 221 84 Lund, Sweden, 2 Unit of Molecular Metabolism, Department of Clinical Sciences and 3 Unit of Islet Cell Physiology, CRC 91:11, 205 02 Malmö, Sweden, 4 Insulin Signal Transduction Group and 5 Connective Tissue Biology, BMC C12, 221 84 Lund, Sweden

* To whom correspondence should be addressed. Tel: +46 462220525; Fax: +46 462220531; Email: jia-yi.li{at}med.lu.se

Received June 1, 2009; Accepted July 20, 2009

Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular β-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing β-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using immunoprecipitation of mutant and wild-type huntingtin in combination with mass spectrometry, we reveal an enhanced and aberrant interaction between mutant huntingtin and β-tubulin, implying the underlying mechanism of impaired intracellular transport. Thus, our findings have revealed a novel pathogenetic process by which mutant huntingtin may disrupt hormone exocytosis from β-cells and possibly impair vesicular transport in any cell that expresses the pathogenic protein.


{dagger} The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.